Department of Immunology and Institute of Medical Sciences, Medical School, Chonbuk National University, Jeonju, Jeonbuk 54907, Republic of Korea.
Department of Oriental Pharmacy, College of Pharmacy and Wonkwang-Oriental Medicine Research Institute, Wonkwang University, Iksan, Jeonbuk 54538, Republic of Korea.
Int J Mol Med. 2017 Oct;40(4):1243-1252. doi: 10.3892/ijmm.2017.3095. Epub 2017 Aug 11.
Triticum aestivum sprout-derived polysaccharide (TASP) has anti-diabetic properties, but no information is available in regards to its protective effect against ethanol-induced hepatic injury. This study aimed to investigate the mechanism behind the protective role of TASP against ethanol-induced liver injury in vivo. Male C57BL/6 mice were administered ethanol with or without TASP for 10 consecutive days by oral gavage. Silymarin was administered in the same manner as a positive control. TASP reduced ethanol-induced hepatic lipid accumulation and serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels. TASP also prevented glutathione (GSH) depletion and increased the superoxide dismutase (SOD) in liver tissue. In addition, TASP significantly inhibited ethanol-induced cytochrome P450 2E1 (CYP2E1) activation, and upregulated the expressions of nuclear factor erythroid 2-related factor 2 (Nrf2) and hemeoxygenase-1 (HO-1), and downregulated NADPH oxidase genes in ethanol fed mice. Furthermore, the upregulation of Nrf2 was found to be regulated by a phosphatidylinositol 3-kinase (PI3K)/Akt pathway. TASP also attenuated hepatic injury by modulation of caspase-3 and apoptosis-associated mitochondrial proteins including B-cell lymphoma-2 (Bcl-2) and Bcl-2-associated X (Bax) in liver tissues of mice. The study demonstrated that TASP treatment protects against ethanol-induced hepatic injury via multiple pathways by inhibiting steatosis and improving antioxidant marker levels during hepatic injury. Such properties provide a basis for therapeutic agents against alcohol-induced liver injury.
小麦芽多糖(TASP)具有抗糖尿病作用,但关于其对乙醇诱导的肝损伤的保护作用尚缺乏信息。本研究旨在探讨 TASP 对体内乙醇诱导肝损伤的保护作用机制。雄性 C57BL/6 小鼠连续 10 天通过口服灌胃给予乙醇和/或 TASP。水飞蓟素以相同方式给药作为阳性对照。TASP 降低了乙醇诱导的肝脂质蓄积和血清丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)水平。TASP 还防止了谷胱甘肽(GSH)耗竭,并增加了肝组织中的超氧化物歧化酶(SOD)。此外,TASP 显著抑制了乙醇诱导的细胞色素 P450 2E1(CYP2E1)激活,并上调了核因子红细胞 2 相关因子 2(Nrf2)和血红素加氧酶-1(HO-1)的表达,并下调了乙醇喂养小鼠中 NADPH 氧化酶基因。此外,发现 Nrf2 的上调受磷脂酰肌醇 3-激酶(PI3K)/Akt 通路调节。TASP 还通过调节肝组织中 caspase-3 和与凋亡相关的线粒体蛋白,包括 B 细胞淋巴瘤-2(Bcl-2)和 Bcl-2 相关 X(Bax),减轻了小鼠肝损伤。该研究表明,TASP 通过抑制肝损伤期间的脂肪变性和改善抗氧化标志物水平,通过多种途径保护肝脏免受乙醇诱导的肝损伤。这些特性为治疗酒精性肝损伤的药物提供了依据。